AAAAAA
Results: 1-25/45
Authors:
FINN IW
AMBINDER RF
Citation: Iw. Finn et Rf. Ambinder, AIDS ONCOLOGY, Current opinion in infectious diseases, 11(1), 1998, pp. 23-27
Authors:
TAO Q
ROBERTSON KD
MANNS A
HILDESHEIM A
AMBINDER RF
Citation: Q. Tao et al., THE EPSTEIN-BARR-VIRUS MAJOR LATENT PROMOTER QP IS CONSTITUTIVELY ACTIVE, HYPOMETHYLATED, AND METHYLATION SENSITIVE, Journal of virology, 72(9), 1998, pp. 7075-7083
Authors:
CONSTANDINOU CM
LEE S
CROCKER J
YOUNG LS
AMBINDER RF
MURRAY PG
Citation: Cm. Constandinou et al., ANALYSIS OF MHC CLASS-I AND TAP EXPRESSION AND LMP2 EPITOPE SEQUENCE IN EBV-POSITIVE HODGKINS-DISEASE, Journal of pathology, 184, 1998, pp. 33-33
Authors:
GLASER SL
AMBINDER RF
DIGIUSEPPE JA
HORNROSS PL
HSU JL
Citation: Sl. Glaser et al., ABSENCE OF EPSTEIN-BARR-VIRUS EBER-1 TRANSCRIPTS IN AN EPIDEMIOLOGICALLY DIVERSE GROUP OF BREAST CANCERS, International journal of cancer, 75(4), 1998, pp. 555-558
Authors:
TSAI ST
JIN YT
MANN RB
AMBINDER RF
Citation: St. Tsai et al., EPSTEIN-BARR-VIRUS DETECTION IN NASOPHARYNGEAL TISSUES OF PATIENTS WITH SUSPECTED NASOPHARYNGEAL CARCINOMA, Cancer, 82(8), 1998, pp. 1449-1453
Authors:
MURRAY PG
CONSTANDINOU CM
CROCKER J
YOUNG LS
AMBINDER RF
Citation: Pg. Murray et al., ANALYSIS OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I, TAP EXPRESSION,AND LMP2 EPITOPE SEQUENCE IN EPSTEIN-BARR VIRUS-POSITIVE HODGKINS-DISEASE, Blood, 92(7), 1998, pp. 2477-2483
Authors:
TAO Q
ROBERTSON KD
MANNS A
HILDESHEIM A
AMBINDER RF
Citation: Q. Tao et al., EPSTEIN-BARR-VIRUS (EBV) IN ENDEMIC BURKITTS-LYMPHOMA - MOLECULAR ANALYSIS OF PRIMARY TUMOR-TISSUE, Blood, 91(4), 1998, pp. 1373-1381
Authors:
GRUFFERMAN S
AMBINDER RF
SHUGART YY
BRECHER ML
GILCHRIST GS
Citation: S. Grufferman et al., INCREASED CANCER RISK IN FAMILIES OF CHILDREN WITH HODGKINS-DISEASE, American journal of epidemiology, 147(11), 1998, pp. 29-29
Authors:
SHEAFFER JM
NICHOLAS J
BRAVO N
BROWNING PJ
DIGIUSEPPE JA
HAYWARD GS
AMBINDER RF
Citation: Jm. Sheaffer et al., LACK OF EXPRESSION OF THE VIRAL IL-6 HOMOLOG IN KSHV-ASSOCIATED TUMORS, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 81-81
Authors:
MOORE SM
AMBINDER RF
Citation: Sm. Moore et Rf. Ambinder, PHARMACOLOGICAL INDUCTION OF EPSTEIN-BARR-VIRUS LYTIC CYCLE - STRATEGIES FOR TUMOR-THERAPY, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 101-101
Authors:
DAVIS JM
LEMAS MV
ORENTAS R
EBY LL
FABIAN D
FLINN I
NOGA SJ
AMBINDER RF
Citation: Jm. Davis et al., EXPANSION OF EPSTEIN-BARR-VIRUS (EBV)-SPECIFIC CYTOTOXIC T-CELLS (CTLS) IN GAS-PERMEABLE CELL-CULTURE BAGS, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 127-127
Authors:
EIGENMANN PA
AMBINDER RF
LEDERMAN HM
Citation: Pa. Eigenmann et al., CHRONIC SINUSITIS WITH ACQUIRED IMMUNOGLOBULIN-A (IGA) DEFICIENCY AFTER BONE-MARROW TRANSPLANTATION, Otolaryngology and head and neck surgery, 117(6), 1997, pp. 226-228
Authors:
ABRAMS RA
LIU PJC
AMBINDER RF
HAULK TL
KORMAN LT
HERMAN MG
JONES RJ
Citation: Ra. Abrams et al., HODGKIN AND NON-HODGKIN-LYMPHOMA - LOCAL-REGIONAL RADIATION-THERAPY AFTER BONE-MARROW TRANSPLANTATION, Radiology, 203(3), 1997, pp. 865-870
Authors:
ROBERTSON KD
AMBINDER RF
Citation: Kd. Robertson et Rf. Ambinder, MAPPING PROMOTER REGIONS THAT ARE HYPERSENSITIVE TO METHYLATION-MEDIATED INHIBITION OF TRANSCRIPTION - APPLICATION OF THE METHYLATION CASSETTE ASSAY TO THE EPSTEIN-BARR-VIRUS MAJOR LATENCY PROMOTER, Journal of virology, 71(9), 1997, pp. 6445-6454
EPSTEIN-BARR VIRUS-ASSOCIATED HODGKINS-DISEASE - EPIDEMIOLOGIC CHARACTERISTICS IN INTERNATIONAL DATA
Authors:
GLASER SL
LIN RJ
STEWART SL
AMBINDER RF
JARRETT RF
BROUSSET P
PALLESEN G
GULLEY ML
KHAN G
OGRADY J
HUMMEL M
PRECIADO MV
KNECHT H
CHAN JKC
CLAVIEZ A
Citation: Sl. Glaser et al., EPSTEIN-BARR VIRUS-ASSOCIATED HODGKINS-DISEASE - EPIDEMIOLOGIC CHARACTERISTICS IN INTERNATIONAL DATA, International journal of cancer, 70(4), 1997, pp. 375-382
Authors:
ROBERTSON KD
AMBINDER RF
Citation: Kd. Robertson et Rf. Ambinder, METHYLATION OF THE EPSTEIN-BARR-VIRUS GENOME IN NORMAL LYMPHOCYTES, Blood, 90(11), 1997, pp. 4480-4484
Authors:
ORENTAS RJ
NILSEN TW
GETTS RC
ROSKOPF SR
AMBINDER RF
Citation: Rj. Orentas et al., EPSTEIN-BARR-VIRUS LOAD DETERMINATION BY CELLULAR DILUTION AND MOLECULAR-DETECTION OF EBER-1 SEQUENCES BY RT-PCR AND DNA DENDRIMERS, Blood, 90(10), 1997, pp. 3931-3931
Authors:
FLINN IW
MORRISON C
MILLER C
AMBINDER RF
JONES RJ
Citation: Iw. Flinn et al., GOOD PROGNOSIS FOR PATIENTS WHO RECEIVE BMT AFTER HISTORY OF LYMPHOMATOUS MENINGITIS, Blood, 90(10), 1997, pp. 1670-1670
Authors:
TAO Q
SWINNEN L
AMBINDER RF
Citation: Q. Tao et al., CONSERVATION OF EPSTEIN-BARR-VIRUS (EBV)CTL EPITOPES IN EBV (-ORGAN TRANSPLANT RECIPIENTS() POSTTRANSPLANT LYMPHOMAS IN SOLID), Blood, 90(10), 1997, pp. 2281-2281
Authors:
SING AP
AMBINDER RF
HONG DJ
JENSEN M
BATTEN W
PETERSDORF E
GREENBERG PD
Citation: Ap. Sing et al., ISOLATION OF EPSTEIN-BARR-VIRUS (EBV)-SPECIFIC CYTOTOXIC T-LYMPHOCYTES THAT LYSE REED-STERNBERG CELLS - IMPLICATIONS FOR IMMUNE-MEDIATED THERAPY OF EBV(-DISEASE() HODGKINS), Blood, 89(6), 1997, pp. 1978-1986
Authors:
AMBINDER RF
ROBERTSON KD
MOORE SM
YANG J
Citation: Rf. Ambinder et al., EPSTEIN-BARR-VIRUS AS A THERAPEUTIC TARGET IN HODGKINS-DISEASE AND NASOPHARYNGEAL CARCINOMA, Seminars in cancer biology, 7(4), 1996, pp. 217-226
Authors:
LIU PC
AMBINDER RF
JONES RJ
ABRAMS RA
Citation: Pc. Liu et al., RADIATION-THERAPY AFTER BONE-MARROW TRANSPLANTATION FOR RESISTANT LYMPHOMA, Radiology, 201, 1996, pp. 804-804
Authors:
ROBERTSON KD
MANNS A
SWINNEN LJ
ZONG JC
GULLEY ML
AMBINDER RF
Citation: Kd. Robertson et al., CPG METHYLATION OF THE MAJOR EPSTEIN-BARR-VIRUS LATENCY PROMOTER IN BURKITTS-LYMPHOMA AND HODGKINS-DISEASE, Blood, 88(8), 1996, pp. 3129-3136
Authors:
LIN AY
KINGMA DW
LENNETTE ET
FEARS TR
WHITEHOUSE JM
AMBINDER RF
JAFFE ES
LEVINE PH
TUCKER MA
Citation: Ay. Lin et al., EPSTEIN-BARR-VIRUS AND FAMILIAL HODGKINS-DISEASE, Blood, 88(8), 1996, pp. 3160-3165
Authors:
DAVIS JM
ORENTAS R
EBY LL
FLINN I
LEMAS MV
NOGA SJ
AMBINDER RF
Citation: Jm. Davis et al., GENERATION EXPANSION OF EPSTEIN-BARR-VIRUS (EBV)-SPECIFIC CYTOTOXIC T-CELLS (CTLS) IN GAS-PERMEABLE CELL-CULTURE BAGS/, Blood, 88(10), 1996, pp. 434-434